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Exploring the cellular uptake and localisation of 
phosphorescent rhenium fac-tricarbonyl 
metallosurfactants as a function of lipophilicity† 
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James A. Platts,a David Lloyd,b Marc Isaacs,c Anthony J. Hayes,c Simon J. Coles, 
 d Mateusz B. Pitak,d Sarah Marchant,e Stephen N. Marriott,e Rudolf K. Allemann,  a Athanasia Dervisi 
 *
a
 
and Ian A. Fallis  *a 
 
A systematic study of the cellular uptake of emissive complexes as a function of their lipophilicity is pre-
sented. Here a series of amphiphilic rhenium fac-tricarbonyl bisimine complexes bearing axial substituted 
imidazole or thiazole ligands, [Re(bpy)(CO)3(ImCnHm)]+ {n = 1 m = 3 (1+), n = 4 m = 9 (2+), n = 8 m = 17 
(3+), n = 12 m = 25 (4+), n = 16 m = 33 (5+), n = 2 m = 3 (6+); bpy = 2,2’-bipyridine, Im = imidazole} and 
[Re(bpy)(CO)3(L)]+ {L = 1-mesitylimidazole, ImMes (7+), 4,5-dimethylthiazole, dmt (8+) and 4-methyl-5-
thiazole-ethanol, mte (9+)} is reported. The X-ray crystal structures of 2+, 8+ and 9+ confirm the geometry 
and expected distribution of ligands and indicated that the plane of the imidazole/thiazole ring is approxi-
mately parallel to the long axis of the bipy ligand. Luminescence studies revealed excellent properties for 
their use in cell imaging with visible excitation and broad emission profiles. Their uptake in two distinct 
species has been examined by fluorescence imaging of the diplomonad fish parasite Spironucleus vortens 
(S. vortens) and rod-shaped yeast Schizosaccharomyces pombe (Schiz. pombe) as a function of their lipo-
philicity. The uptake of the complexes was highest for the more lipophilic 2+–5+ in both S. vortens and 
Schiz. pombe in which the long alkyl chain aids in crossing bilipid membranes. However, the increased 
lipophilicity of longer chains also resulted in greater toxicity. Localisation over the whole cell varied with 
diﬀering alkyl chain lengths with complex 2+ preferentially locating to the nucleus of S. vortens, 3+ showing 
enhanced nuclear partitioning in Schiz. pombe, and 4+ for the remaining cell wall bound in the case of S. 
vortens. Interestingly, complexes of intermediate lipophilicity such as 7+ and 8+ showed reason-able 
uptake, proved to be non-toxic, and were capable of crossing exterior cell walls and localising in the 
organelles of the cells. 
 
 
 
 
 
 
 
aSchool of Chemistry, Main Building, Cardiﬀ  University, Cardiﬀ  CF10 3AT, 
UK. E-mail: fallis@cardiﬀ .ac.uk, hallettaj@cardiﬀ .ac.uk, 
DervisiA@Cardiﬀ .ac.uk; Fax: +44 (0)29-20874030; Tel: +44 (0)29-20879316 
 
bCardiﬀ  School of Biosciences, Main Building, Museum Avenue, Cardiﬀ , CF10 
3AT, UK 
 
cConfocal Microscopy Unit, Cardiﬀ  School of Biosciences, Life Sciences 
Building, Cardiﬀ , CF10 3US, UK 
 
dUK National Crystallographic Service, Chemistry, Faculty of Natural and 
Environmental Sciences, University of Southampton, Highfield, Southampton, SO17 
1BJ, UK 
eDefence Science Technology Laboratory, (DSTL), Porton Down, Salisbury, SP4 
0JQ, UK 
 † Electronic supplementary information (ESI) available: cif file, full tables of crys-
tallographic data, luminescence spectra for all compounds and images of con-focal 
microscopy. CCDC 969748, 990428 and 990429. For ESI and crystallo-graphic data in 
CIF or other electronic format see DOI: 10.1039/c8dt00669e 
 
 
Introduction 
 
Surface active metal complexes, known as metallosurfactants,1 may 
be defined as amphiphilic species in which the polar ‘head-group’ of 
a surfactant incorporates a metal complex. While ‘standard’ 
surfactants have found ubiquitous appli-cations in industrial, medical 
and domestic scenarios for many decades, metallosurfactants are a 
relatively new class of material. Since the lipophilicity of a 
metallosurfactant may be readily varied by changes in the size of the 
hydrophobic component of the amphiphilic structure,2 we have 
chosen to examine the potential suitability of a range of 
phosphorescent rhenium(I) fac-tricarbonyl metallosurfactants as 
cellular imaging agents. Phosphorescent complexes of the fac-
[ReI(CO)3(N–N)] {(N–N) = bis-imine ligand}3 and in particular 
amphiphilic complexes4 have been extensively studied for their 
luminescent properties, including recent applications, along 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
with RuII and IrIII complexes, as phosphors in live-cell imaging 
confocal fluorescence microscopy.5 Variation of the bis-imine or the 
axial ligands greatly influences the properties of the complexes such 
as solubility, stability, cytotoxicity, lifetimes, cellular uptake, 
membrane permeability and organelle localis-ation within the cells. 
Their ease of visible excitation, large Stokes shifts and long-lived 
3MLCT excited states, promoted by heavy metal assisted spin–orbit 
coupling and inter-system crossing, aid in distinguishing between 
emission from the complexes and that of matrix auto-fluorescence, 
thus improv-ing contrast in confocal imaging work. In addition, 
selective imaging can be achieved by noting that the photophysical 
pro-perties of this type of material are microenvironment sensi-tive.6 
Tricarbonyl complexes have also proven useful in imaging within 
parasites.7 Whilst many metal-based cellular imaging probes are 
now employed to great eﬀ ect, their localis-ation within cells is a 
complex function of both their physical properties and reactivity, 
and thus their eﬀ ective design can be somewhat serendipitous. As an 
aid to the rational design of these materials we felt it to be valuable 
to systematically vary the lipophilicity of a model system to 
determine the eﬀ ect of hydrophobicity on the biodistribution of 
metal based phos-phors. In addition, Re complexes are attracting 
much attention as potential chemotherapeutic agents,8 while the beta 
emitters 186Re and 188Re are potentially useful radiotherapeutic iso-
topes.9 Hence understanding how to modulate rhenium cellu-lar 
distribution is of particular medicinal value. 
 
 
Long chain methylimidazolium compounds are amphi-philic, 
which is they possess an organic hydrophobic chain termi-nated with 
a polar head group. These compounds have been extensively studied 
as surfactants,10 ionic liquids,11 liquid crys-tals12 and as precursors 
to N-heterocyclic carbenes.13 In the current paper the methyl group 
has been replaced by the cat-ionic fac-{ReI(CO)3(N–N)} moiety to 
aﬀord a range of phosphor-escent complexes, bearing varying alkyl, 
vinyl and aromatic groups. The longer alkyl chain variants are 
metallosurfactants and are suited to penetrate into the lipid bilayer of 
live cells with the cationic nature assisting crossing membranes via 
passive diﬀusion. Here, the uptake and localisation of the complexes 
was examined as a function of the complex lipo-philicity by 
confocal fluorescence imaging using two micro-organisms, namely 
the diplomonad fish parasite Spironucleus vortens (S. vortens) and 
rod-shaped yeast Schizosaccharomyces pombe (Schiz. pombe). 
 
trimethylaniline, glyoxal and formaldehyde in the presence of NH4Cl 
according to a literature procedure.14 Again the product was purified 
by bulb-to-bulb vacuum distillation using a Kügelrohr apparatus. All 
other ligands are commercially available. 
 
Reaction of the imidazole/thiazole ligands with the precur-sor 
complex [Re(CO)3(bpy)(NCMe)]BF4 in hot CHCl3 for 16 h, 
followed by purification by column chromatography led to the 
complexes [Re(CO)3(bpy)L]BF4 (Fig. 1) 1+–9+ in moderate to good 
yields (61–93%) as bright yellow powders. The complexes were 
characterised by 1H and 13C–{1H} NMR spectroscopy, low and high 
resolution electrospray mass spectrometry, HPLC, IR, UV-vis and 
fluorescence spectroscopies and elemental analysis. The complexes 
1+ and 7+ have been previously 
 
reported as the PF6− and OTf − salts for study of the energy gap 
law15,29 and C–N bond cleavage of the bipyridine16 respect-ively; 
however, characterisation data are included in the Experimental 
section for comparison and completeness. 
 
For reasons of synthetic accessibility, we adopted this 3 car-
bonyl, chelating bis-imine plus an axial ligand approach. It should be 
noted however that such complexes may well undergo loss of the 
axial ligand as demonstrated by Leonidova et al.17 and that these 
complexes are likely to be less stable than those of comparable 
tridentate ligands.18 1H NMR spec-troscopy confirmed the 
coordination of the axial ligand in each case with, for example, an 
upfield shift of the sharp imid-azole moiety resonances of ImC4H9 
from 7.41, 6.99 and 6.84 ppm in the free ligand to broad singlets at 
6.93, 6.78 and 
 
6.73 ppm in 2+. In addition, the sharp imidazole resonances of 
ImMes show an upfield shift from 7.47, 7.27 and 6.93 ppm in the 
free ligand to broad singlets at 7.20, 6.83 and 6.58 ppm in 7+. It is 
noteworthy that the thiazole ligand mte, the axial ligand of complex 
9+, is a component of thiamine (vitamin B1) when alkylated by a 
methylene bridged aminopyrimidine to form a cationic species 
(analogous to the cationic rhenium complexes here). Uptake of 
thiamine by cells of the blood and other tissues is believed to occur 
via active transport and passive diﬀusion.19 This inexpensive 
thiazole has also found 
 
 
 
 
 
Results and discussion 
 
Synthesis and characterisation of the ligands and complexes 
 
The 1-alkylimidazole ligands (ImC4H9, ImC8H17, ImC12H25 and 
ImC16H33) were prepared in good yields (∼85%) by react-ing 
imidazole with 1 molar equivalent of the appropriate bromoalkane in 
DMF at 120 °C in the presence of base. After aqueous work-up, the 
ligands were purified by bulb-to-bulb vacuum distillation using a 
Kügelrohr apparatus. The mesityl substituted ligand, ImMes, was 
synthesised by reacting 2,4,6- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 The complexes [Re(CO)3(bpy)L]+ 1+–9+ in this study and the 
structure of ctc (10). 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
use as a food additive. Here, its coordination to rhenium results in an 
upfield shift of the sharp thiazole moiety reso-nance in the 1H NMR 
spectrum from 8.39 ppm in the free ligand to 7.88 ppm in complex 
9+, along with a downfield shift of the methyl resonance from 2.24 
ppm in the free ligand to 2.37 ppm in 9+, whilst leaving the 
resonances of the two methylene groups virtually unchanged. Solid-
state IR studies (as KBr discs) of the complexes revealed two 
absorption bands between 2030 and 1910 cm−1 for the rhenium 
bound carbonyl stretches consistent with pseudo C3v symmetry; a 
broader band at ca. 1920 cm−1 consists of two merged bands as seen 
in many previous examples.3–5 Both low and high resolution mass 
spectrometry were obtained in which the correct isotopic distribution 
was observed for the monocationic species [M − BF4]+ in each case. 
The purity of the complexes was confirmed by elemental analysis 
with the expected composition with 4+ being observed as a 1 : 3 
Et2O solvate. 
 
 
X-ray crystallography studies 
 
Yellow columnar crystals of [Re(CO)3(bpy)(ImC4H9)]BF4 2+, 
columnar crystals of [Re(CO)3(bpy)(dmt)]BF4 8+ (as a CHCl3 
solvate) and prismatic crystals of [Re(CO)3(bpy)(mte)]OTf 9+ 
(grown as the triflate salt from an alternate sample) suitable for X-
ray diﬀ raction studies were grown by slow vapour diﬀusion of Et2O 
into a concentrated solution of the complex in CHCl3. The lattice 
parameters, data collection and structure refinement details are 
shown in Table 1 with selected bond lengths and angles reported in 
Table 2 (Fig. 2). 
 
 
The crystallographic studies confirmed the proposed for-mulation 
with fac-coordination of the three carbonyl ligands, chelating 
bipyridine and the imidazole/thiazole ligand co-ordinated in the axial 
position {Fig. 3(a)–(c)}. In accordance with numerous related fac-
rhenium tricarbonyl structures the complex shows distorted 
octahedral geometry around the metal centre with generally typical 
bond lengths for co-ordinated bipyridine and axial N-donor 
ligands.3–5 The Re(1)– N(3) bond lengths {2.179(2), 2.243(2) and 
2.231(6) Å for 2+, 8+ and 9+ respectively}are longer than Re(1)–
N(1) {2.169(2), 2.188 
 
(3) and 2.188(5) Å}and Re(1)–N(2) {2.171(2), 2.177(3) and 2.174 
 
(5) Å} bond lengths for all three complexes, particularly for thiazole 
complexes, 8+ and 9+ in which the diﬀ erence is more pronounced. 
This is consistent with the reported structure of the imidazole based 
guanine complex [Re(CO)3(bpy)(gua)]+, the only structurally 
characterised example of a fac-rhenium 
 
tricarbonyl complex with 2,2′-bipyridine and an axial imid-azole 
ligand.20 However, the only other example of a fac-rhenium 
tricarbonyl complex bearing an axial imidazole 
 
ligand (i.e. R = H from Fig. 1), which has 1,10-phenanthroline as the 
diimine ligand, [Re(CO)3( phen)(ImH)]+, does not show extended 
Re–Naxial bond lengths and displays three essentially identical Re–N 
bond lengths.21 The structures of 8+ and 9+ described here are the 
first reported structures of fac-rhenium tricarbonyl complexes 
bearing axial thiazole ligands. The 
 
Re(1)–N(1) bond lengths in thiazole complexes {2.188(3) and 
2.188(5) Å for 8+ and 9+ respectively} are longer than the imid-azole 
complex 2+ {2.169(2) Å}. In addition, the Re(1)–N(3) bond lengths 
are considerably longer in the thiazole complexes 
 
 
Table 1 Single crystal diﬀ raction data parameters for [Re(CO)3(bpy)(ImC4H9)]BF4 (2+), [Re(CO)3(bpy)(mte)]OTf (8+) and [Re(CO)3(bpy)(mte)]OTf (9+) 
 
 
 [Re(CO)3(bpy)(ImC4H9)]BF4 2+ [Re(CO)3(bpy)(dmt)]BF4 8+ [Re(CO)3(bpy)(mte)]OTf 9+ a 
    
CCDC depository number 969748 990428 990429 
Formula C20H20BF4N4O3Re C19H16BCl3F4N3O3ReS C20H17F3N3O7ReS2 
Formula weight 637.41 745.77 718.69 
Temperature/K 100(2) 100(2) 100(2) 
Wavelength/Å 0.71075 0.71075 0.71075 
Crystal size/mm3 0.420 × 0.060 × 0.040 0.280 × 0.050 × 0.040 0.12 × 0.10 × 0.04 
Crystal system Monoclinic Monoclinic Orthorhombic 
Space group P21/n P21/c P212121 
a/Å 11.1861(6) 11.0109(8) 12.1102(9) 
b/Å 12.2320(5) 17.8468(13) 13.1182(9) 
c/Å 16.1257(11) 13.4164(9) 14.8639(10) 
α/° 90.00 90.00 90.00 
ȕ/° 95.466(7) 111.137(2) 90.00 Ȗ/° 90.00 90.00 90.00 
Volume/Å3 2196.4(2) 2459.1(3) 2361.3(3) 
Z 4 4 4 
F000 1232 1432 1392 
ȝ/mm−1 5.597 5.411 5.394 
θ range for data collection 3.036 − 27.482° 3.024 − 27.476° 2.67 − 27.51° 
Index ranges −14 ≤ h ≤ 14, −15 ≤ k ≤ 11, −13 ≤ −14 ≤ h ≤ 14, −23 ≤ k ≤ 22, −17 ≤ l −15 ≤ h ≤ 15, −17 ≤ k ≤ 11, −19 ≤ 
 l ≤ 20 ≤ 15 l ≤ 12 
Reflections collected 15 288 17 474 18 399 
Independent reflections (Rint) 5016 (0.0287) 5579 (0.0471) 5408(0.0307) 
Final R indices [F2 > 2ı(F2)]: 0.0201, 0.0494 0.0300, 0.0842 0.0258, 0.0658 
R1, wR2    
R indices (all data) 0.0219, 0.0501 0.0317, 0.0854 0.0261, 0.0660 
 
a
 Structure is a racemic twin ∼40 : 60 ratio. Flack parameter = 0.371(3).22 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Selected bond lengths (Å) and angles (°) for [Re(CO)3(bpy)(ImC4H9)]BF4 (2+), [Re(CO)3(bpy)(mte)]OTf (8+) and [Re(CO)3(bpy)(mte)]OTf (9+) and 
the values calculated from DFT studies for the model complexes 1+ and 8+ 
 
 
Bond length (Å)/angle (°) 2+ Calculated values 8+ 9+ Calculated values 
      
Re(1)–N(1) 2.169(2) 2.185 2.188(3) 2.188(5) 2.189 
Re(1)–N(2) 2.171(2) 2.185 2.177(3) 2.174(5) 2.188 
Re(1)–N(3) 2.179(2) 2.213 2.243(2) 2.231(6) 2.255 
Re(1)–C(11) 1.929(3) 1.925 1.933(3) 1.938(7) 1.923 
Re(1)–C(12) 1.922(3) 1.925 1.937(4) 1.930(8) 1.923 
Re(1)–C(13) 1.926(3) 1.931 1.924(3) 1.926(7) 1.927 
C(11)–O(1) 1.145(3) 1.157 1.142(4) 1.144(9) 1.158 
C(12)–O(2) 1.145(3) 1.157 1.140(5) 1.146(9) 1.158 
C(13)–O(3) 1.149(3) 1.155 1.148(4) 1.138(8) 1.154 
N(3)–C(14) 1.329(3) 1.334 1.314(4) 1.324(9) 1.323 
N(4)/S(1)–C(14) 1.341(3) 1.355 1.695(3) 1.681(7) 1.707 
N(1)–Re(1)–C(11) 174.78(9) 172.07 172.8(1) 174.9(3) 171.75 
N(2)–Re(1)–C(12) 171.94(9) 172.07 175.4(1) 174.0(3) 171.72 
N(3)–Re(1)–C(13) 176.60(9) 178.99 177.0(1) 175.5(3) 177.13 
C(11)–Re(1)–C(12) 86.85(11) 90.12 86.35(1) 85.3(3) 91.02 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Cation structure and atom labelling scheme of (a) [Re(CO)3(bpy)(ImC4H9)] (2+) and (b) [Re(CO)3(bpy)(dmt)] (8+) and (c) [Re(CO)3(bpy)(mte)] (9+) 
(displacement ellipsoids are at 70% probability, hydrogen atoms and counter ions are removed for clarity). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Frontier orbitals of (a) [Re(CO)3(bpy)(ImCH3)]+ 1+ and (b) [Re 
(CO)3(bpy)(dmt)]+ 8+. 
 
 
 
{2.243(2) and 2.231(6) Å respectively} than the imidazole complex 
{2.179(2) Å}. However, the Re(1)–N(2) bond lengths are 
indistinguishable. The Re–Caxial and Re–Cequatorial bond 
lengths are essentially identical in all three complexes, as are the C–
O bonds. 
 
In each case, the heterocyclic (imidazole or thiazole) axial donor 
ligands are positioned mutually perpendicular to the plane of the 
bipyridine ligand (i.e. mutually parallel to the 2,2′,5,5′-position of the 
bipyridine). The N(4)–C(14) bond of 2+ {1.341(3) Å} is shorter than 
the S(1)–C(14) bonds of 8+ {1.695(3) Å} and 9+ {1.681(7) Å} 
reflecting the delocalised aromatic nature of the imidazole ligands 
compared with the thiazole ligands. Interestingly, for 9+ the 
bipyridine ligand is slightly tilted with the N(3)–Re(1)–N(2) angle 
{88.49(15)°} much larger than the N(3)–Re(1)–N(1) angle 
{81.63(15)°}. 
 
The bond lengths and angles of 2+, 8+ and 9+ were com-pared 
with the optimised values calculated from density func-tional theory 
(DFT) for structurally simplified models (Table 2). In general, a 
reasonable agreement is obtained between the theoretical and 
experimentally observed bond lengths, although some small 
diﬀ erences are found. The calcu-lated Re–Nbipyridine bond lengths 
are longer for 2+ (2.185 Å) with Re(1)–N(1) {2.169(2) Å} and 
Re(1)–N(2) {2.171(2) Å} 0.016 and 0.014 Å shorter. In addition, the 
calculated Re–Naxial bond 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
lengths are longer for 2+ (2.213 Å) with Re(1)–N(3) {2.179(2) Å} 
0.034 Å shorter. In the case of the thiazole complexes 8+ and 9+, 
there is excellent agreement of Re–N bond lengths between 
calculated values and experimental values. All Re–N bonds are 
predicted to be longer for the thiazole complexes than for the 
imidazole complex as seen experimentally. 
 
The surface activity of the complexes could not be directly 
measured due to insuﬃcient solubility in aqueous media, pre-cluding 
the determination of critical micelle concentrations. Further 
lipophilicity could not be measured via, for example, octanol/water 
partition coeﬃcient measurements due to a weakly emulsifying 
nature of the metallosurfactant species. Thus to generate a 
quantitative measure of the complex hydro-philic or lipophilic 
character we calculated the surface area of the polar and non-polar 
components. Approximate structures of all nine cationic complexes 
were manually constructed from X-ray of 2+ and 8+, and geometry 
of the isolated cation fully optimised using the PM6-DH2 method23 
as implemented within MOPAC2012.24 Coordinates were extracted, 
and used as input for a locally modified25 version of MOLVOL26 in 
order to calculate molecular volume and surface area data. This 
version automatically assigns van der Waals radii to all atoms, using 
standard values for C, H, O, N and S and a default value of 2 Å for 
Re. Table 3 reports values calculated in this manner. Here we see as 
expected the more surface active species have a higher total : polar 
area. The consequences of this are reflected below in the cellular 
uptake studies. 
 
 
Electronic structure and spectroscopy 
 
In order to determine the nature of the electronic transitions within 
this class of complex, DFT calculations (computed using the 
B3PW91 hybrid functional) were performed of the structurally 
simplified complexes of ImCH3 1+ and dmt 8+. In these examples, 
an assessment of the frontier orbitals pro-vided a qualitative insight 
into the HOMO (Highest Occupied Molecular Orbital) and LUMO 
(Lowest Unoccupied Molecular Orbital) energy levels. For the 
amide-functionalized complexes described here the energy levels of 
both the HOMO and LUMO are suﬃciently diﬀ erent ( E > 0.2 eV) 
from the other MOs to be considered independent. Population 
analyses revealed that the distribution of the frontier orbitals over the 
various 
 
 
ligands and metal is very similar in each case. The HOMOs (E = 
−9.16 and −9.41 eV respectively) are mainly situated on Re (ca. 
60%), the three carbonyl ligands (ca. 24%) and imidazole/ thiazole 
(ca. 10%) whilst the LUMOs (E = −5.72 and −5.83 eV respectively) 
are located primarily on the bpy ligand (ca. 90%). The pictorial 
representations and relative distributions of the frontier orbitals are 
shown in Fig. 3 and Table 4, respectively. 
 
The mixed metal/ligand character is consistent with pre-vious 
descriptions for complexes of this type27 and suggests an excited 
state delocalised positive hole. The results suggest the lowest energy 
absorption should be reported as a HOMO → π* (bpy), in turn 
suggesting that significant MLCT and LLCT char-acter be predicted 
for the lowest energy excited state. The absorption spectra for the 
complexes show two main features with ligand-centred transitions 
dominating <320 nm and broad visible absorption at 330–450 nm 
associated with LLCT/ MLCT character (Fig. 4, Table 5). 
 
The room temperature luminescence properties of com-plexes 
1+–9+ were assessed in (aerated) CHCl3 and DMSO/water (2 : 98), 
the solvent mixture used for confocal microscopy 
 
 
 
 
Table 4 Percentage distribution of HOMO and LUMO over complexes 
 
 
 
[Re(CO)3(bpy)   [Re(CO)3(bpy)(dmt)]+ 
 (ImCH3)]+ 1+   8+  
       
 HOMO LUMO HOMO LUMO 
      
Re 61.0 3.7  60.2 3.6 
ImCH3/dmt 9.6 2.8  9.5 3.2 
CO (eq 1) 6.0 1.1  6.3 1.2 
CO (eq 2) 6.0 1.1  6.5 1.1 
CO (ax) 11.9 0.9  11.5 0.9 
bpy 5.5 90.4 
 
5.9 90.1 
       
 
 
 
Table 3 Volume (Å3), total surface area, polar surface area and non-polar 
surface area (all Å2) 
 
 
  Total Polar Non-polar   
  surface surface surface Total : polar  
Complex Volume area area area area 
 
       
1+ 402.67 395.95 75.92 320.03 5.2  
2+ 473.07 467.14 74.93 392.20 6.2  
3+ 567.54 564.21 74.84 489.37 7.5  
4+ 662.16 661.36 74.88 586.48 8.8  
5+ 756.73 758.49 74.84 683.66 10.1  
6+ 416.23 407.33 75.91 331.42 5.4  
7+ 542.39 526.87 72.71 454.16 7.2  
8+ 427.04 403.87 100.29 303.58 4.0  
9+ 457.30 431.53 100.67 330.86 4.3 Fig. 4  UV-vis spectra of complexes 1+–9+ as CHCl3 solutions (5 × 10−5 M). 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
           
 
         
 
Table 5  Photophysical properties of rhenium complexes 1+–9+     
     
Compound Ȝmax (İ/L mol−1 cm−1)a/nm Ȝex CHCl3 (H2O)b/nm Ȝem CHCl3/nm (Ĳ aeratedc/ns) Ȝem H2O/nmb (Ĳ aeratedc/ns) 
1+ 240 (22 900), 282 (17 525), 355 (4800) 404 (368) 568 (70) 580 (22) 
2+ 240 (22 650), 282 (17 950), 355 (4915) 372 (366) 571 (65) 579 (28) 
3+ 240 (17 400), 276 (18 050), 354 (2600) 383 (368) 571 (67) 568 (29) 
4+ 240 (23 650), 282 (16 420), 354 (4350) 369 (365) 571 (63) 564 (42) 
5+ 246 (21 650), 282 (20 000), 355 (4450) 366 (366) 573 (62) 534 (497) 
6+ 245 (21 125), 276 (13 475), 351 (2400) 369 (360) 568 (83) 577 (33) 
7+ 248 (23 675), 273 (22 425), 356 (4300) 362 (361) 561 (92) 558 (24) 
8+ 251 (30 000), 346 (4225) 366 (360) 542 (308) 556 (96) 
9+ 253 (25 975), 353 (4800) 365 (360) 552 (244) 556 (107) 
a
 Measured as CHCl3 solutions (5 × 10−5 M). b Measured as a DMSO/water (2 : 98) solution. c Excitation wavelength of 372 nm. 
 
 
 
 
studies. The imidazole complexes 1+–7+ were emissive around 570 
nm in CHCl3. The relatively long lifetimes (CHCl3, Ĳ = 62–92 ns) 
are attributed to the MLCT/LLCT character, as dis-cussed in the 
context of the DFT results. The thiazole com-plexes 8+ and 9+ show 
substantially blue shifted emission (at ca. 540–550 nm), possibly 
due to the electron poor nature of the axial donors, as seen in the 
longer Re–N bond lengths in the thiazole versus imidazole structures 
(thiazoles generally react slowly with electrophiles, e.g. nitration, in 
comparison to imidazoles28). In addition the thiazole based 
complexes exhibit significantly extended lifetimes (308 and 244 ns 
respectively). It therefore appears that the thiazole axial ligands do 
not present the number of quenching pathways as the imidazole 
analogues. When the luminescence properties are studied in aerated 
aqueous conditions (water/DMSO 98 : 2) the characteristics are 
much more dependent on the amphi-philic nature of the compounds. 
For the complexes of the least lipophilic ligands 1+, 2+, 6+, 8+ and 
9+ the emission is red shifted by ca. 5–15 nm compared to that in 
CHCl3. The lumi-nescent lifetimes are shorter lived, 20–30 ns for 
the imidazole complexes and 96–107 ns for the thiazole complexes. 
In more polar solvents, such as water (dielectric constants: water 80; 
CHCl3 5) stabilise dipolar CT excited states resulting in red-shifted 
emission.29 For the slightly longer chain variants (and moderately 
lipophilic ligands) 3+, 4+ and 7+ the emission is blue shifted by ca. 5 
nm compared to that in CHCl3, whilst the luminescent lifetimes 
remain shorter lived at 30–40 ns. Interestingly, for the imidazole 
complexes bearing the longest (hexadecyl) lipophilic chain 5+, both 
the steady state and emis-sion lifetime properties show profound 
changes, the emission is blue shifted by 39 nm compared to that in 
CHCl3 (Fig. 5) with an associated luminescent lifetime of 497 ns, 
suggesting that the 3MLCT state is destabilised in water, raising the 
π* energy and thus the dπ–π* separation. It was previously noted 
that complexes bearing ligands incorporating long alkyl chains were 
able to ‘wrap’ the lipophilic chain around the complex, under 
aqueous conditions, protecting the bipyridine unit from the water. 
Both the blue shift in emission and the longer life-time suggest that 
the excited state is shielded from solvent quenching eﬀ ects.30 
Overall, these characteristic absorption and emission properties, with 
the absorption maxima around 355 nm (tailing away to 440 nm), 
along with broad emission 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Excitation (dashed) and emission (solid) spectra for [Re 
(CO)3(bpy)(ImC16H33)]+ 5+ in CHCl3 (black) and water/DMSO (98 : 2) 
(blue). 
 
 
 
(450–730 nm) render these complexes highly compatible with 
confocal fluorescence microscopy. 
 
Confocal fluorescence microscopy 
 
Confocal fluorescence microscopy was used to study the fluo-
rescence imaging capability of the complexes (1+–9+) using two 
diﬀ ering cells, the anaerobically grown aerotolerant protistan fish 
parasite Spironucleus vortens (S. vortens) and unicellular eukaryote 
“fission yeast” Schizosaccharomyces pombe (Schiz. pombe). The 
diplomonad fish protist, S. vortens inhabits the gut as a parasite of 
ornamental fish (e.g. Angel fish), where O2 partial pressures are low. 
During evolution they have lost the machinery of fully aerobic 
organisms (e.g. the rod-shaped yeast Schiz. pombe). Thereby 
mitochondria carrying out oxi-dative phosphorylation as a 
mechanism for energy production have evolved into a dihydrogen 
producing organelle, the hydro-genosome. Another major diﬀ erence 
is that the protist, lacks the rigid, clearly defined multi-layered, rod-
shaped cell wall 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
characteristic of the immotile yeast, and has instead a protein-
phospholipid plasma membrane covered with highly flexible and 
structured glycoprotein-calyx. The parasite propels itself forward, 
driven by eight flagella. Whereas the yeast grows until it becomes a 
fourteen micrometer long cylinder then divides transversely to form 
a pair of short rods, the halving of cell volume by cell division and 
development of new flagella in the diplomonad is more complex. 
These contrasting and changing morphological characteristics during 
growth and development are revealed by the imaging techniques 
employing the more appropriate of the novel lumophores described 
here. In all cases an excitation wavelength of 405 nm was used 
together with a detection wavelength between 515–600 nm. Selected 
images of confocal fluorescence microscopy studies are pre-sented 
here, with all images available in the ESI.† 
 
Firstly, the imidazole complexes which incorporate CH3 1+ and 
C2H3 (vinyl) 6+ groups, the least lipophilic of the com-plexes, are 
not readily taken up intracellularly and are there-fore not toxic to S. 
vortens. Complex 1+ was mounted in ‘Vectashield’ (an anti-fade 
mounting medium) containing the DNA/RNA-binding probe DAPI 
(4′,6-diamidino-2-phenylin-dole), and rapid motility of the 
binucleate organisms was evident. The resulting continuing motility 
of the organism pre-cluded acquisition of sharp images of the 
autofluorescence of poorly stained organisms, even after partial 
arrest of motility using 2,2,2-trichloro-1,1-diol (chloral hydrate) as 
anaesthetic. These were not useful lumophores for confocal 
fluorescence microscopy and we present no images. This was 
particularly disappointing for complex 6+ in which the reactivity of 
vinyl group may have aided in targeting specific organelles. 
 
The longer chain variants 2+–5+ all revealed good to excel-lent 
uptake consistent with the highly lipophilic/amphiphilic structures, 
which will assist passive diﬀusion across mem-branes. The variation 
in structure, and amphiphilic nature, however, revealed major 
diﬀ erences in the imaging capability across the series. Complex 2+ 
was not toxic at the concen-trations used over the duration of the 
experiment, revealed good uptake and gave very bright images of S. 
vortens struc-tures, surface and exo-cellular surfaces, e.g. plasma 
membranes, with minimal penetration into nuclei {Fig. 6(a) and 
(b)}. The flagellar-driven motility and forward propulsive swimming 
was maintained across the entire population. Consequently, in order 
to obtain sharply focused images, it was necessary to anaesthetise 
using chloral hydrate immedi-ately before microscopical 
examination. A heterogeneous sized 
 
 
population of Schiz. pombe (a consequence of long and short rods 
typical of asynchronously dividing individual cells) showed 
moderate to good uptake of 2+ in, in particular, younger (shorter) 
cells with nonspecific localisation within the cell organelles {Fig. 
6(c) and (d)}. No localised intense regions of rhenium-based 
emission were observed in the cytoplasm, indicating non-specific 
distribution rather than specific uptake in any particular organelles. 
 
As a positive control, ctc (10, Fig. 1, 5-cyano-2,3-di-(p-tolyl) 
tetrazolium chloride), a cationic organic dye extensively employed in 
the study of cells as an indicator of cellular redox activity,31 was 
used to stain metabolically active cells grown from the same batch. 
The non-fluorescent compound 10 is reduced in the cell, either via 
reductase activity or through direct reaction with NADH or NADPH 
producing an insoluble, deep coloured fluorescent formazan 
precipitate. It is thought that the positive charge in the tetrazolium is 
the primary factor responsible for their cellular uptake driven by the 
plasma and energy-transducing electrochemical membrane 
potentials.32 In the aerobically-grown yeast the latter are the 
mitochondria, whereas in the anaerobic S. vortens, the corres-
ponding organelles are the hydrogenosomes. 
 
For S. vortens the ctc/formazan showed good uptake (Fig. 7(a)) 
and localisation in several organelles including the hydrogenosomes 
(redox-active organelles equivalent to the mitochondria of aerobic 
eukaryotic organisms). For Schiz. pombe it again showed good 
uptake with selective staining of the nuclei {Fig. 7(b) and (c)} within 
the yeast cells (both nuclei of older elongated cells). 
 
Complex 3+ was taken up avidly by both S. vortens and Schiz. 
pombe. It was, however, toxic at the concentrations employed in this 
study. For S. vortens, background cytosolic binding indicated 
multiple binding at non-specific locations and images were not 
clearly defined. For Schiz. pombe, 3+ 
 
 
 
 
 
 
 
 
 
 
Fig. 7 Fluorescence, Normarski DIC and overlaid images of (a) S. vortens 
containing ctc and (b) and (c) Schiz. pombe containing ctc (scale bars 5 
ȝm). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Fluorescence, Normarski diﬀerential interference contrast (DIC) and overlaid images of (a) and (b) S. vortens containing 2+ and (c) and (d) Schiz. 
pombe containing 2+ (scale bars 5 ȝm). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 (a) Fluorescence emission spectrum (Ȝex = 405 nm), (inset: range of 
sample studied) and (b) fluorescence, Normarski DIC, and overlaid images 
of S. vortens containing 3+ (scale bars 5 ȝm). 
 
 
 
shows preferential uptake into the nuclei, but also with general 
background cytosolic labelling. About 30% of popu-lation are 
faintly phosphorescent (those with very pronounced diﬀ erential 
image contrast in walls). A fluorescence emission spectrum from 
confocal microscopy on a sample region of S. vortens containing 3+ 
was recorded (Fig. 8) and revealed a maximum {Ȝmax (em)} around 
556 nm, identical to that of the emission wavelength measured by 
fluorescence spectroscopy for 3+ in water (Table 5 and ESI†). 
 
For the longer chain variants 4+ (C12) and 5+ (C16), the rhenium 
complexes are toxic at the concentrations used. 4+ was mounted in 
‘Vectrashield’ containing DAPI. Complex 4+ showed bright images 
of S. vortens structures, surface and 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Fluorescence, Normarski DIC, and overlaid images of (a) S. vortens 
containing 4+ and (b) and (c) Schiz. pombe containing 5+ (scale bars 5 
ȝm). 
 
 
exocellular surfaces, e.g. plasma membranes, with minimal 
penetration into nuclei {Fig. 9(a)}. However, staining with complex 
5+ led to complete destruction of all (only one sur-vived intact with 
unobserved flagella) S. vortens cells (see ESI†). For Schiz. pombe 
4+ shows good uptake with no specific foci of fluorescence (see 
ESI†) whereas 5+ is taken up well around the periphery of the cell 
revealing labelling of the smooth endo-plasmic membranes, 
including those of the Golgi apparatus with no penetration into the 
organelles {Fig. 9(b) and (c)}. The rigid exocellular surface of the 
Schiz. pombe outer wall is most likely responsible for the cells 
remaining intact. 
 
Finally, we discuss the complexes of moderately lipophilic 
ligands 1-mesitylimidazole (ImMes) 7+ and the thiazoles, 4,5-
dimethylthiazole (dmt) 8+ and 4-methyl-5-thiazoleethanol (mte) 9+. 
Complexes 7+–9+ were not toxic at the concentrations used over the 
duration of the experiment and it was necessary to anaesthetise using 
chloral hydrate immediately before microscopical examination. 
Complex 7+ revealed good uptake and gave very bright images of S. 
vortens localising in orga-nelles in middle of the cell {Fig. 10(a)}. 
However, it was only taken up by very few cells (only those which 
appear to be in the process of partitioning) of Schiz. pombe giving a 
hetero-geneous population of stained cells with no specific localis-
ation (see ESI†). The complexes bearing thiazole ligands show 
generally adequate uptake in both S. vortens and Schiz. pombe 
giving a heterogeneous population for both cells, with 8+ showing 
higher concentrations around the cell membrane of S. vortens {Fig. 
10(b)} and 9+ showing slightly greater localis-ation in nucleus {Fig. 
10(d)}. Complex 8+ stained a sub-population of Schiz. pombe, 
which appears to be only in shorter, recently divided cells (but not all 
divided cells), with localisation in organelles. 
 
 
The imaging results presented here suggest that functiona-lised 
rhenium imidazole/thiazole complexes are useful as bio-compatible 
fluorophores. The specific nature of the pendant R-group can be used 
to tune the imaging capability of the com-plexes from poor uptake 
(1+ and 6+) to good uptake/poor local-isation (2+), to excellent 
uptake and distinct regions of fluo-rescence (3+, 4+ and 8+). The 
toxicity of the complexes can be controlled with properties ranging 
from non-toxic (2+, 7+, 8+ and 9+), through toxic at the 
concentrations used (3+ and 4+), and toxic with complete destruction 
of cells (5+). The increased liphophilic nature of the complexes 
appears to increase the uptake of the complexes into the cells, but 
also increases the toxicity of the fluorophores. The imaging results 
clearly show 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10 Fluorescence, Normarski DIC, and overlaid images of (a) S. vortens containing 7+, (b) S. vortens containing 8+ (c) Schiz. pombe containing 8+ 
and (d) S. vortens containing 9+ (scale bars 5 ȝm). 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
that simple tuning of the amphiphilic nature of the complexes can 
profoundly alter the uptake, localisation and toxicity of the probes, 
with the moderately amphiphilic complexes oﬀ ering the greatest 
balance between all considerations. 
 
 
Conclusions 
 
In conclusion, this paper has described the synthesis and structural 
characterisation of a series of cationic rhenium com-plexes, in which 
the amphiphilic nature of the complexes is controlled by the 
variation of the lipophilicity of the axial ligand. The optical 
properties are dominated by MLCT/LLCT transitions, as predicted 
by DFT calculations, facilitating visible absorption and eﬀ ective 
broad emission characteristics. These properties render the 
complexes highly compatible with confocal microscopy. Cellular 
imaging studies were performed on both aerotolerant protistan fish 
parasite S. vortens and uni-cellular eukaryote “fission yeast” Schiz. 
pombe showing a large variation in the imaging capabilities. 
Importantly, the cellular uptake, toxicity and specific localisation 
can be controlled by the lipophilic nature of the axial ligands. For 
the complexes described here, the most encouraging results were 
presented by those complexes of the moderately lipophilic ligands, 
i.e. good uptake, non-toxic and specific localisation, particularly 7+ 
and 8+ which showed localisation in the nuclei. Complexes of the 
most lipophilic ligand generally showed localisation within the cell 
membranes and increasing toxicity with increasing lipophilicity. In 
addition, under the conditions employed there was little evidence of 
photobleaching. Therefore by careful selection of the axial ligand 
this type of complex could be adapted for radioimaging nuclides, for 
example as 99mTc(I) compounds, whilst retaining the required 
physical characteristics for cellular imaging using confocal 
fluorescence microscopy. 
 
 
 
 
Experimental 
 
All reactions were performed with the use of vacuum line and 
Schlenk techniques. Reagents were commercial grade and were used 
without further purification. 1H and 13C–{1H} NMR spectra were 
recorded on an NMR-FT Bruker 400 MHz or Joel Eclipse 300 MHz 
spectrometer and recorded in CDCl3. 1H and 13C–{1H} NMR 
chemical shifts (į) were determined relative to internal TMS and are 
given in ppm. Low- and high-resolution mass spectra were obtained 
by the staﬀ  at Cardiﬀ  University. UV-Vis studies were performed 
on a Jasco V-570 spectrophoto-meter as CHCl3 solutions (5 × 10−5 
M). Photophysical data were obtained on a JobinYvon-Horiba 
Fluorolog spectrometer fitted with a JY TBX picoseconds 
photodetection module as CHCl3 or water/DMSO (98 : 2) solutions. 
Emission spectra were uncorrected and excitation spectra were 
instrument corrected. The pulsed source was a Nano-LED 
configured for 372 nm output operating at 500 kHz. Luminescence 
lifetime profiles were obtained using the JobinYvon-Horiba 
FluoroHub single 
 
 
 
photon counting module and the data fits yielded the lifetime values 
using the provided DAS6 deconvolution software. Microanalyses 
were performed by London Metropolitan University, UK. 
 
X-ray data collection and processing 
 
Diﬀ raction data were collected at 100 K on Rigaku AFC12 
goniometer equipped with an enhanced sensitivity (HG) Saturn 
724+detector mounted at the window of an FR-E+Superbright 
MoKα (Ȝ = 0.71075 Å) rotating anode genera-tor with HF Varimax 
optics.33 X-ray data were recorded and integrated using Rigaku 
CrystalClear34 software. Crystal struc-ture was solved by direct 
methods using SHELXS-2013 35 and charge flipping methods using 
SUPERFLIP36 and refined on Fo2 by full-matrix least squares 
refinement using SHELXL-2013/2014 package. All non-hydrogen 
atoms were refined with anisotropic displacement parameters. All 
hydro-gen atoms were added at calculated positions and refined 
using a riding model with isotropic displacement parameters based 
on the equivalent isotropic displacement parameter (Ueq) of the 
parent atom. Figures were created using the ORTEP3 software 
package.37 CCDC depository numbers: 969748, 990428 and 
990429.† 
 
 
DFT studies 
 
Scalar relativistic calculations were performed on the Gaussian 09 
program.38 Geometry optimisations were carried out without 
constraints using the B3PW91 functional. The LANL2DZ basis set 
was used for the Re centres, and was invoked with pseudo-potentials 
for the core electrons, a 6-31G (d,p) basis set for all nitrogen, oxygen 
and coordinating atoms with a 6-31G basis set for all remaining 
atoms. All optimis-ations were followed by frequency calculations to 
ascertain the nature of the stationary point (minimum or saddle 
point). 
 
Cell culture and imaging 
 
Organisms employed were the fission yeast, Schiz. pombe 972 h-, 
and the single cell protist fish parasite, S. vortens ATCC 50386. The 
yeast was grown and maintained on Sabouraud Maltose Agar (Difco) 
then transferred to unbaﬄed conical flasks (50 ml) containing 10 ml 
of YE’PD liquid medium (0.3% yeast extract, 1% peptone and 1% 
glucose), and grown under aerobic conditions for 2 days on a rotary 
shaker at 150 rpm. Removal of nutrients was by centrifugation for 3 
min at 2000 rpm (3000g) and resuspension in 50 mM phosphate 
buﬀ er at pH 7.2. S. vortens was grown anaerobically in stop-pered 
tubes on a rich serum-containing medium, harvested and washed as 
described previously.39 Cytotoxicity was deter-mined by exposure to 
the complexes at 1–100 µM for inhi-bition of growth at intervals for 
up to 36 h. The homogeneous cell suspension was then distributed 
into 1 ml aliquots, with each aliquot being subject to incubation with 
a diﬀ erent imaging probe. These luminescent probes were initially 
dis-solved in dimethyl sulfoxide (DMSO) (5 mg ml−1) before being 
added to the cell suspensions, with a final concentration of 100 µg 
ml−1 (corresponding to about 110–190 µM) before incu- 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
bation at 20 °C for 30 min. While it is known that DMSO can cause 
instability in biological active metal complexes,40 in the current 
work the complexes were found to be stable in DMSO. Cells were 
finally washed in phosphate buﬀer saline (PBS, pH 7.2), removing 
agent from the medium, then harvested by centrifugation (5 min, 
800g) and mounted on a slide for imaging. Preparations were viewed 
using a Leica TCS SP2 AOBS confocal laser scanning microscope 
with excitation at 405 nm and detection band ranging from 515–600 
nm. 
 
Synthesis 
 
ImC4H9.  Imidazole  (5.05  g,  74.18  mmol),  bromobutane 
 
(8.5 ml, 78.78 mmol) and KOH (5.1 g, 90.91 mmol) were heated in 
DMF (60 ml) at 120 °C for 16 h. After cooling, water (150 ml) was 
added and the product was extracted with CH2Cl2 (100 ml). The 
organic phase was separated, washed with water (100 ml) and brine 
(2 × 100 ml) and dried over MgSO4. After filtering, the solvent was 
removed in vacuo and the crude product dissolved in toluene before 
solvent removal in vacuo once more. The product was purified by 
bulb-to-bulb vacuum distillation using Kügelrohr apparatus to give a 
colourless oil. Yield = 7.74 g, 62.33 mmol (84%). 1H NMR data 
were as previously reported.41 
 
ImC8H17, ImC12H25 and ImC16H33 were prepared similarly 
from imidazole and 1-bromooctane, 1-bromododecane or 1-
bromohexadecane respectively. 1H NMR data were as pre-viously 
reported.42 
 
ImMes. Prepared by slight modification of literature pro-cedure. 
2,4,6-trimethylaniline (6.8 g, 0.05 mol) in MeOH (25 mL) was 
stirred with 30% aqueous glyoxal (8.1 mL, 0.05 mol) for 16 h at 
room temperature. A bright yellow mixture was formed. Then, 
NH4Cl (5.4 g, 0.1 mol) was added followed by 37% aqueous 
formaldehyde (8 mL, 0.1 mol). The mixture was diluted with MeOH 
(200 ml) and the resulting mixture was refluxed for 1 h. H3PO4 (7 
mL, 85% soln.) was added over a period of 10 min. The resulting 
mixture was then stirred at reflux overnight. After removal of the 
solvent, the dark residue was poured onto ice (100 g) and bacified 
with aqueous 40% KOH solution until pH 9. The resulting mixture 
was extracted with EtOAc (2 × 100 ml). The organic phases were 
combined and washed with H2O, brine and dried with anhydrous 
MgSO4. After filtering, the solvent was removed and the residue 
was purified by bulb-to-bulb vacuum distillation using Kügelrohr 
apparatus at 240 °C (some unreacted 2,4,6-tri-methylaniline initially 
distils as a colourless oil at lower tem-perature). 1H NMR data were 
as previously reported.14 
 
[Re(CO3)(bpy)(ImCH3)]BF4 (1+). [Re(CO)3(bpy)(MeCN)]BF4 
 
(0.083 g, 0.149 mmol) and 1-methylimidazole (0.014 g, 0.170 
mmol) were heated at reflux in CHCl3 for 16 h. The solvent was 
then removed in vacuo. The product was purified by column 
chromatography (silica/CH2Cl2). Unreacted methyl imidazole was 
eluted with CH2Cl2 and the product as the first yellow band with 
CH2Cl2/MeOH (95 : 5). The product was recrystallised from 
CH2Cl2/Et2O to give a bright yellow powder. Yield = 0.055 g, 0.091 
mmol (61%). 1H NMR (250 MHz, CDCl3) įH = 8.91 (2H, d, 3JHH = 
4.4 Hz), 8.53 (2H, d, 3JHH = 8.1 Hz), 
 
8.20 (2H, app t. {coincident dd}, 3JHH = 7.8 Hz), 7.56 (2H, app t., 
3JHH = 6.3 Hz), 6.88 (1H, broad s), 6.85 (1H, broad s), 6.69 (1H, 
broad s), 3.49 (3H, s) ppm. 13C NMR (75 MHz, CDCl3) įC = 156.3, 
152.7, 141.1, 130.9, 129.6, 128.4, 125.8, 122.5, 33.6 ppm. UV-vis 
(CHCl3): Ȝmax (İ/L mol−1 cm−1) 240 (22 900), 282 (17 525), 355 
(4800) nm. Elemental analysis: calcd 
 
(%) for C17H14N4O3ReBF4: C, 34.30, H, 2.37, N, 9.41; found: C, 
34.28, H, 2.49, N, 9.38. ES MS found m/z 509.2, calculated m/z 
509.1 for [M − BF4]+. HR MS found m/z 507.0594, calculated m/z 
507.0596 for [C17H14N4O3185Re]+. IR (KBr) Ȟ(CO) = 2026, 1916 
cm−1. 
 
[Re(CO3)(bpy)(ImC4H9)]BF4 (2+). Prepared similarly from 
[Re(CO)3(bpy)(MeCN)]BF4 (0.085 g, 0.152 mmol) and ImC4H9 
(0.019 g, 0.153 mmol). Yield = 0.069 g, 0.108 mmol (71%). 1H 
NMR (250 MHz, CDCl3) įH = 8.90 (2H, d, 3JHH = 4.3 Hz), 8.58 
(2H, d, 3JHH = 7.5 Hz), 8.21 (2H, app t., 3JHH = 7.5 Hz), 
 
7.57 (2H, app t., 3JHH = 6.3 Hz), 6.93 (1H, broad s), 6.78 (1H, broad 
s), 6.73 (1H, broad s), 3.75 (2H, t, 3JHH = 7.5 Hz), 1.10 (2H, m), 
0.75 (2H, m), 0.42 (3H, m) ppm. 13C NMR (75 MHz, CDCl3) įC = 
155.8, 152.6, 141.2, 138.7, 130.7, 128.3, 125.6, 120.6, 48.1, 32.5, 
19.5, 13.5 ppm. UV-vis (CHCl3): Ȝmax (İ/L mol−1 cm−1) 240 (22 
650), 282 (17 950), 355 (4915) nm. Elemental analysis: calcd (%) for 
C20H20N4O3ReBF4: C, 37.69, H, 3.16, N, 8.79; found: C, 37.74, H, 
3.07, N, 8.69. ES MS found 
 
m/z 551.1, calculated m/z 551.1 for [M − BF4]+. HR MS found m/z 
549.1042, calculated m/z 549.1065 for [C20H20N4O3185Re]+. 
 
IR (KBr) Ȟ(CO) = 2026, 1915 cm−1. 
[Re(CO3)(bpy)(ImC8H17)]BF4  (3+).  Prepared  similarly  from 
[Re(CO)3(bpy)(MeCN)]BF4 (0.080 g, 0.143 mmol) and ImC8H17 
 
(0.031 g, 0.172 mmol). Yield = 0.069 g, 0.099 mmol (69%). 
1H NMR (250 MHz, CDCl3) įH = 8.93 (2H, d, 3JHH = 4.5 Hz), 
8.60 (2H, d, 3JHH = 8.2 Hz), 8.22 (2H, app t., 3JHH = 6.6 Hz), 
7.49 (2H, app t., 3JHH = 4.5 Hz), 6.97 (1H, s), 6.71 (2H, broad s), 
3.75 (2H, t, 3JHH = 7.4 Hz), 3.41 (2H, app q (coincident tt), 3JHH = 
7.40 Hz), 1.25–1.05 (10H, m), 0.81 (3H, t, 3JHH = 7.0 Hz) ppm. 13C 
NMR (75 MHz, CDCl3) įC = 195.2, 191.1, 154.9, 152.3, 140.5, 
138.6, 128.6, 127.9, 124.6, 120.4, 47.5, 30.9, 29.8, 28.3, 28.2, 25.5, 
21.9, 13.4 ppm. UV-vis (CHCl3): Ȝmax (İ/L mol−1 cm−1) 240 (17 
400), 276 (18 050), 354 (2600) nm. Elemental analysis: calcd (%) for 
C24H28N4O3ReBF4: C, 41.56, H, 4.07, N, 8.08; found: C, 41.63, H, 
4.07, N, 7.92. ES MS found m/z 607.2, 
 
calculated m/z 607.2 for [M − BF4]+. HR MS found m/z 605.1681, 
calculated m/z 605.1691 for [C24H28N4O3185Re]+. IR (KBr) Ȟ(CO) 
= 2027, 1910 cm−1. 
 
[Re(CO3)(bpy)(ImC12H25)]BF4 (4+). Prepared similarly from 
[Re(CO)3(bpy)(MeCN)]BF4 (0.080 g, 0.143 mmol) and ImC12H25 
(0.034 g, 0.144 mmol). Yield = 0.068 g, 0.090 mmol (63%). 1H 
NMR (250 MHz, CDCl3) įH = 8.91 (2H, d, 3JHH = 4.3 Hz), 8.62 
(2H, d, 3JHH = 8.0 Hz), 8.21 (2H, app t., 3JHH = 7.6 Hz), 7.47 (2H, 
app t., 3JHH = 6.0 Hz), 6.97 (1H, s), 6.73 (2H, 2 × d, 3JHH = 5.1 Hz), 
3.77 (2H, t, 3JHH = 7.2 Hz), 1.59–1.46 (6H, m), 
 
1.28–1.03 (14H, m), 0.80 (3H, t, 3JHH = 6.4 Hz) ppm. 13C NMR (75 
MHz, CDCl3) įC = 196.1, 191.8, 155.8, 152.8, 141.2, 139.0, 130.0, 
128.5, 125.7, 121.0, 48.3, 31.9, 30.5, 29.7, 29.6, 29.5, 29.4, 29.3, 
29.0, 26.3, 22.7, 14.2 ppm. UV-vis (CHCl3): Ȝmax (İ/L mol−1 cm−1) 
240 (23 650), 282 (16 420), 354 (4350) nm. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elemental analysis: calcd (%) for C28H36N4O3ReBF4·3Et2O: C, 
 
49.43, H, 6.84, N, 5.76; found: C, 49.44, H, 6.56, N, 6.13. ES MS 
found m/z 663.2, calculated m/z 663.2 for [M − BF4]+. HR MS 
 
found m/z 661.2297, calculated m/z 661.2317 for 
[C28H36N4O3185Re]+. IR (KBr) Ȟ(CO) = 2028, 1925 cm−1. 
 
[Re(CO3)(bpy)(ImC16H33)]BF4 (5+). Prepared similarly from 
[Re(CO)3(bpy)(MeCN)]BF4 (0.100 g, 0.180 mmol) and ImC16H33 
(0.058 g, 0.198 mmol). Recrystallisation from CH2Cl2/Et2O did not 
initially precipitate the product, and a lowering of volume by slow 
evaporation was required. Yield = 0.112 g, 0.139 mmol (77%). 1H 
NMR (400 MHz, CDCl3) įH = 8.91 (2H, d, 3JHH = 5.5 Hz), 8.59 
(2H, d, 3JHH = 8.2 Hz), 8.21 (2H, app t., 3JHH = 
 
8.7 Hz), 7.57 (2H, app t., 3JHH = 7.1 Hz), 6.95 (1H, s), 6.75 (1H, br 
s), 6.72 (1H, br s), 3.74 (2H, t, 3JHH = 7.4 Hz), 1.53–1.47 (6H, m), 
1.23–1.05 (22H, m), 0.81 (3H, t, 3JHH = 7.0 Hz) ppm. 13C NMR (75 
MHz, CDCl3) įC = 155.2, 152.5, 141.1, 138.9, 130.5, 128.2, 125.9, 
120.7, 48.4, 32.2, 30.6, 30.0, 29.7, 29.6, 25.1, 29.4, 29.2, 29.1, 28.6, 
27.0, 26.4, 22.9, 22.8, 14.2 ppm. UV-vis (CHCl3): Ȝmax (İ/L mol−1 
cm−1) 246 (21 650), 282 (20 000), 355 (4450) nm. Elemental 
analysis: calcd (%) for C32H44N4O3ReBF4: C, 47.70, H, 5.50, N, 
6.95; found: C, 47.60, H, 5.38, N, 7.04. ES MS found m/z 719.3, 
calculated m/z 719.3 for [M − BF4]+. HR MS found m/z 717.2940, 
calculated m/z 717.2943 for [C32H44N4O3185Re]+. IR (KBr) Ȟ(CO) 
= 2027, 1905 cm−1. 
 
[Re(CO3)(bpy)(ImC2H3)]BF4  (6+).  Prepared  similarly  from 
[Re(CO)3(bpy)(MeCN)]BF4  (0.116 g, 0.209 mmol) and 1-vinyl- 
 
imidazole (20 ȝl, 0.221 mmol). Yield = 0.109 g, 0.175 mmol 
(86%). 1H NMR (250 MHz, CDCl3) įH  = 8.90 (2H, d, 3JHH  = 
6.5 Hz), 8.56 (2H, d, 3JHH = 8.1 Hz), 8.29 (1H, s), 8.21 (2H, app t., 
3JHH = 7.8 Hz), 7.58 (2H, app t., 3JHH = 6.6 Hz), 7.05 (1H, br s), 
6.73 (1H, br s), 5.45 (1H, dd, 3JHH = 15.7 Hz, 2JHH = 2.3 Hz), 
5.45 (1H, dd, 3JHH  = 15.7 Hz, 2JHH  = 2.3 Hz), 5.45 (1H, dd, 
3JHH = 15.7 and 2.3 Hz) ppm. 13C NMR (75 MHz, CDCl3) įC = 
 
156.0, 153.1, 141.0, 139.2, 130.1, 128.8, 128.0, 126.0, 116.4, 
105.2 ppm. UV-vis (CHCl3): Ȝmax (İ/L mol−1 cm−1) 245 (21 125), 
 
276 (13 475), 351 (2400) nm. Elemental analysis: calcd (%) for 
C19H17N4O3ReBF4: C, 35.60, H, 2.32, N, 9.22; found: C, 35.46, H, 
2.19, N, 9.27. ES MS found m/z 521.1, calculated m/z 521.1 
for [M − BF4]+. HR MS found m/z 519.0590, calculated m/z 
519.0596 for [C18H14N4O3185Re]+. IR (KBr) Ȟ(CO) = 2023, 
 
1919 cm−1. 
 
[Re(CO3)(bpy)(ImMes)]BF4 (7+). Prepared similarly from 
[Re(CO)3(bpy)(MeCN)]BF4 (0.105 g, 0.181 mmol) and mesityl-
imidazole (ImMes) (0.039 g, 0.210 mmol). Yield = 0.107 g, 0.153 
mmol (81%). 1H NMR (400 MHz, CDCl3) įH = 9.07 (2H, d, 3JHH = 
5.5 Hz), 8.94 (2H, d, 3JHH = 8.3 Hz), 8.40 (2H, app t. (coincident 
dd), 3JHH = 7.4 Hz), 7.70 (2H, app t., 3JHH = 7.9 Hz), 7.20 (1H, s), 
6.95 (2H, s), 6.83 (1H, br s), 6.58 (1H, br s), 2.33 (3H, s), 1.74 (6H, 
s) ppm. 13C NMR (75 MHz, CDCl3) įC = 156.0, 152.2, 152.1, 
141.8, 140.2, 139.5, 134.4, 129.5, 129.1, 128.9, 126.4, 124.0, 21.5, 
17.0 ppm. UV-vis (CHCl3): Ȝmax (İ/L mol−1 cm−1) 248 (23 675), 
273 (22 425), 356 (4300) nm. Elemental analysis: calcd (%) for 
C25H22N4O3ReBF4·0.5CH2Cl2: C, 42.75, H, 3.17, N, 7.96; found: 
C, 42.25, H, 3.60, N, 7.82. ES MS found m/z 613.1, calculated m/z 
612.6 for [M − BF4]+. HR 
 
MS found m/z 611.1213, calculated m/z 611.1222 for 
[C25H22N4O3185Re]+. IR (KBr) Ȟ(CO) = 2027, 1925 cm−1. 
 
[Re(CO3)(bpy)(dmt)]BF4 (8+). Prepared similarly from 
[Re(CO)3(bpy)(MeCN)]BF4 (0.080 g, 0.143 mmol) and 4,5-
dimethyl-thiazole (0.017 g, 0.150 mmol). Yield = 0.080 g, 0.128 
mmol (90%). 1H NMR (250 MHz, CDCl3) įH = 8.87 (2H, d, 3JHH = 
5.2 Hz), 8.71 (2H, d, 3JHH = 8.5 Hz), 8.26 (2H, app t. (coincident 
dd), 3JHH = 7.5 Hz), 7.72 (1H, s), 7.61 (2H, app t., 3JHH = 8.0 Hz), 
2.44 (3H, m), 2.28 (3H, s) ppm. 13C NMR (75 MHz, CDCl3) įC = 
155.8, 154.6, 152.8, 150.2, 141.7, 129.1, 128.4, 126.3, 16.7, 12.3 
ppm. UV-vis (CHCl3): Ȝmax (İ/L mol−1 cm−1) 251 (30 000), 346 
(4225) nm. Elemental analysis: calcd (%) for C18H15N3O3SReBF4: 
C, 34.51, H, 2.41, N, 6.71; found: C, 34.45, H, 2.93, N, 6.63. ES MS 
found m/z 540.0, calculated m/z 540.0 
 
for [M − BF4]+. HR MS found m/z 538.0368, calculated m/z 
358.0364 for [C18H15N3O3S185Re]+. IR (KBr) Ȟ(CO) = 2025, 1901 
cm−1. 
 
[Re(CO3)(bpy)(mte)]BF4 (9+). Prepared similarly from 
[Re(CO)3(bpy)(MeCN)]BF4 (0.094 g, 0.170 mmol) and 4-methyl-5-
thiazoleethanol (25 ȝL, 0.208 mmol). Yield = 0.103 g, 0.157 mmol 
(93%). 1H NMR (400 MHz, CDCl3) įH = 8.95 (2H, d, 3JHH = 5.3 
Hz), 8.65 (2H, d, 3JHH = 8.2 Hz), 8.22 (2H, app. t, 3JHH = 7.9 Hz), 
7.88 (1H, s), 7.61 (2H, app. t, 3JHH = 7.9 Hz), 3.64 (2H, t, 3JHH = 
5.7 Hz), 2.81 (2H, t, 3JHH = 5.7 Hz), 2.37 (3H, s), 3.65 (1H, br s) 
ppm. 13C NMR (75 MHz, CDCl3) įC = 196.2, 190.3, 155.9, 155.6, 
153.0, 150.2, 141.4, 132.3, 128.4, 126.4, 61.2, 30.3, 15.4 ppm. UV-
vis (CHCl3): Ȝmax (İ/L mol−1 cm−1) 253 (25 975), 353 (4800) nm. 
Elemental analysis: calcd (%) for C19H17N3O4SReBF4: C, 34.76, H, 
2.61, N, 6.40; found: C, 34.59, H, 2.61, N, 6.28. ES MS found m/z 
570.0, calculated m/z 570.0 
 
for [M − BF4]+. HR MS found m/z 568.0466, calculated m/z 
568.0469 for [C19H17N3O4S185Re]+. IR (KBr) Ȟ(CO) = 2025, 
 
1915 cm−1. 
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